DANAHER CORPORATION's ticker is DHR and the CUSIP is 235851102. A total of 1,978 filers reported holding DANAHER CORPORATION in Q2 2022. The put-call ratio across all filers is 1.13 and the average weighting 0.6%.
About DANAHER CORPORATION
Danaher Corporation is a global science and technology company that designs, manufactures, and markets innovative products and services to professional, medical, industrial, and commercial customers. The company operates through four segments: Life Sciences, Diagnostics, Dental, and Environmental & Applied Solutions.
Danaher's Life Sciences segment provides a range of research tools to scientists around the world, including mass spectrometry, chromatography, and automation systems. The Diagnostics segment offers a broad range of diagnostic products, including clinical chemistry, immunoassay, microbiology, and molecular diagnostic systems. The Dental segment provides a range of dental equipment and consumables, including imaging systems, dental instruments, and consumables. The Environmental & Applied Solutions segment offers a range of products and services to help customers protect the environment and improve productivity.
Danaher has a strong track record of growth and innovation, driven by its focus on continuous improvement and customer satisfaction. The company has a culture of operational excellence, which has enabled it to consistently deliver high-quality products and services to its customers. Danaher's management team is highly experienced and has a proven track record of creating value for shareholders.
In conclusion, Danaher Corporation is a well-established and innovative company that is well-positioned to continue delivering strong growth and value to its shareholders. With its focus on operational excellence and customer satisfaction, Danaher is a company that investors should keep an eye on.
It's important to note that this information is for educational purposes only and has not been fact-checked. As with any investment, it's important to do your own research and consult with a financial advisor before making any investment decisions.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $13,424,297 | -2.6% | 60,999 | +6.2% | 3.13% | +4.9% |
| Q2 2023 | $13,786,080 | +2.3% | 57,442 | +7.5% | 2.99% | -0.5% |
| Q1 2023 | $13,473,050 | -13.7% | 53,456 | -9.1% | 3.00% | -16.5% |
| Q4 2022 | $15,609,350 | -5.1% | 58,810 | -7.6% | 3.59% | -7.9% |
| Q3 2022 | $16,448,000 | +9.3% | 63,681 | +7.3% | 3.90% | +15.5% |
| Q2 2022 | $15,044,000 | -58.9% | 59,341 | -52.5% | 3.38% | -2.7% |
| Q1 2022 | $36,628,000 | +125.1% | 124,872 | +125.1% | 3.47% | +13.1% |
| Q4 2021 | $16,273,000 | +0.9% | 55,481 | +4.7% | 3.07% | -2.9% |
| Q3 2021 | $16,127,000 | +12.8% | 52,974 | -0.6% | 3.16% | +12.7% |
| Q2 2021 | $14,298,000 | +27.6% | 53,280 | +7.0% | 2.80% | +15.6% |
| Q1 2021 | $11,204,000 | +5.4% | 49,777 | +4.0% | 2.42% | -0.4% |
| Q4 2020 | $10,632,000 | -50.2% | 47,863 | -51.7% | 2.43% | -10.9% |
| Q3 2020 | $21,334,000 | +243.2% | 99,078 | +181.8% | 2.73% | +56.7% |
| Q2 2020 | $6,216,000 | +425.9% | 35,155 | +311.7% | 1.74% | +310.8% |
| Q1 2020 | $1,182,000 | +25.9% | 8,540 | +31.4% | 0.42% | +68.9% |
| Q3 2019 | $939,000 | +1.1% | 6,500 | 0.0% | 0.25% | +1.6% |
| Q2 2019 | $929,000 | +17.3% | 6,500 | +8.3% | 0.25% | +4.2% |
| Q1 2019 | $792,000 | +19700.0% | 6,000 | +14534.1% | 0.24% | +23600.0% |
| Q4 2018 | $4,000 | 0.0% | 41 | 0.0% | 0.00% | 0.0% |
| Q3 2018 | $4,000 | – | 41 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| ARTHUR M. COHEN & ASSOCIATES, LLC | 217,436 | $53,823,432 | 13.80% |
| Defender Capital, LLC. | 152,962 | $37,949,802 | 13.74% |
| Bancreek Capital Management, LP | 60,890 | $15,106,809 | 13.58% |
| BOONE CAPITAL MANAGEMENT LLC | 129,163 | $32,045,340 | 10.11% |
| Eagle Health Investments LP | 175,085 | $43,438,589 | 9.57% |
| Third Point | 2,450,000 | $607,845,000 | 9.22% |
| Clio Asset Management LLC | 41,695 | $10,344,530 | 9.04% |
| Consulta Ltd | 500,000 | $124,050,000 | 8.91% |
| Riverstone Advisors, LLC | 47,960 | $11,799,701 | 8.16% |
| CADEN CAPITAL PARTNERS, LP | 123,755 | $27,215,377 | 7.66% |